|
GPX8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.835400E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.702400E-03 |
| Normal-vs-Stage2 |
2.509800E-01 |
| Normal-vs-Stage3 |
1.350430E-01 |
| Normal-vs-Stage4 |
1.541730E-02 |
| Stage1-vs-Stage2 |
3.048200E-01 |
| Stage1-vs-Stage3 |
1.639400E-01 |
| Stage1-vs-Stage4 |
8.297200E-01 |
| Stage2-vs-Stage3 |
9.992600E-01 |
| Stage2-vs-Stage4 |
3.555000E-01 |
| Stage3-vs-Stage4 |
2.680400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.256900E-03 |
| Normal-vs-AfricanAmerican |
5.946200E-01 |
| Normal-vs-Asian |
1.258700E-03 |
| Caucasian-vs-AfricanAmerican |
2.753800E-01 |
| Caucasian-vs-Asian |
1.718410E-01 |
| AfricanAmerican-vs-Asian |
8.772500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.239900E-02 |
| Normal-vs-Female |
1.748400E-02 |
| Male-vs-Female |
9.445200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.660700E-03 |
| Normal-vs-Age(41-60Yrs) |
1.683610E-02 |
| Normal-vs-Age(61-80Yrs) |
1.049840E-01 |
| Normal-vs-Age(81-100Yrs) |
9.482000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.225400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.058000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.560800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.181600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.797800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.320000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.803700E-02 |
| Classical-VS-Follicular |
4.772800E-01 |
| Classical-VS-Other |
4.114200E-01 |
| Classical-VS-Normal |
1.218430E-02 |
| Tall-VS-Follicular |
4.578000E-01 |
| Tall-VS-Other |
7.918200E-02 |
| Tall-VS-Normal |
4.750800E-01 |
| Follicular-VS-Other |
3.897800E-01 |
| Follicular-VS-Normal |
1.366990E-01 |
| Other-VS-Normal |
4.382500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.938200E-03 |
| Normal-vs-N1 |
1.116990E-03 |
| N0-vs-N1 |
1.830390E-01 |
|
|
